Why HCA Healthcare, Inc. (HCA) stock moved
HCA Healthcare, Inc. (HCA) shares climbed 5.6% to $429.19 as of August 22, 2026, a significant gain from the prior close of $406.27. BestStocks flagged the session as a material change for HCA. Below, we break down what changed for HCA, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
HCA climbed 5.6% to $429.19
HCA climbed 5.6% in its latest session, moving from $406.27 to $429.19.
What it means for HCA Healthcare, Inc. investors
For HCA Healthcare, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Strong 5.6% price move; HCA Healthcare rallied 6.05% to $413.18 following upbeat second-quarter earnings reported on July 27, according to Benzinga. Weighing against that: HCA Healthcare, Inc. (HCA) moved −3.77% from $385.74 to $371.18 on 2026-07-17; HCA Healthcare, Inc. (HCA) moved -3.90% from $406.59 to $390.74 on 2026-07-13. Wall Street's consensus price target sits at $455.19, implying +6.1% upside from $429.19. Over the past 90 days analysts logged 0 upgrades and 1 downgrade. BestStocks rates the overall signal quality low (54/100). With earnings roughly 62 days out, the next report is the most likely near-term test of the move.
HCA price reaction
HCA last traded at $429.19, up $22.92 (+5.64%) from the previous close of $406.27. The session traded on 1.3× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $371.87 and $429.19, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on HCA Healthcare, Inc. (HCA)
The consensus analyst price target on HCA Healthcare, Inc. (HCA) is $455.19, 6.1% above the recent $429.19. Over the past 90 days analysts logged 0 upgrades, 19 maintains, and 1 downgrade. Here is how the bullish and bearish cases on HCA line up.
The bullish case
- Wall Street's consensus price target of $455.19 implies +6.1% upside from $429.19.
- The Street's most bullish target is $579.00 (+34.9%).
- Strong 5.6% price move.
- HCA Healthcare rallied 6.05% to $413.18 following upbeat second-quarter earnings reported on July 27, according to Benzinga.
- HCA Healthcare, Inc. (HCA) moved +4.19% from $363.60 to $378.85 on July 15, 2026.
The bearish case
- The most bearish analyst target is $369.00 (-14.0%).
- 1 analyst downgrade in the past 90 days, most recently Barclays to Equal Weight (2026-07-08).
- HCA Healthcare, Inc. (HCA) moved −3.77% from $385.74 to $371.18 on 2026-07-17.
- HCA moved -2.95% from $423.11 to $410.61 on 2026-07-08.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 22, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for HCA
In-depth HCA event analyses
Frequently asked questions about HCA
Why did HCA Healthcare, Inc. (HCA) stock move?
HCA climbed 5.6% to $429.19. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did HCA stock rise?
HCA gained 5.64% ($22.92) versus the prior close of $406.27, last trading at $429.19 on 1.3× average volume.
When is HCA Healthcare, Inc.'s next earnings date?
HCA's next earnings report is estimated for 2026-10-23 — about 62 days away.
What is the analyst price target for HCA?
The consensus analyst price target for HCA is $455.19, about 6.1% above the current $429.19. Over the past 90 days, analysts recorded 0 upgrades, 19 maintains, and 1 downgrade.
How BestStocks tracks HCA
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared HCA-specific materiality thresholds, triggering an evidence check. It draws on 16 tracked change events for HCA, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 22, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.